￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Alpelisib plus fulvestrant meets primary PFS endpoint in CDK4/6 inhibitor-pretreated patients with PIK3CA mutant HR+/HER2 breast cancer

2026-02-01 22:25:32

Check Details
Which is better, fostatinib/fotantinib or eltrombopag?

2026-02-01 22:25:32

Check Details
Treatment and relief methods for side effects of Serputinib/Serpatinib (Ruitu)

2026-02-01 22:25:32

Check Details
FDA grants accelerated approval to Voyxact (sibprenlimab-szsi) to reduce proteinuria in adults with primary immunoglobulin A nephropathy

2026-02-01 22:25:32

Check Details
KEYNOTE-775 confirms broad efficacy of lenvatinib plus pembrolizumab in advanced endometrial cancer

2026-02-01 22:25:32

Check Details
Is Belumosudil tablets currently on the market? What is the sales situation?

2026-02-01 22:25:32

Check Details
A comprehensive analysis of the precautions for using Brivaracetam

2026-02-01 22:25:32

Check Details
What is the relevant marketing information about fezolinetant?

2026-02-01 22:25:32

Check Details
What are the indications for Obeticholic acid?

2026-02-01 22:25:32

Check Details
What are the possible adverse reactions of Obeticholic acid?

2026-02-01 22:25:32

Check Details
Deuterated colexitinib (decavatinib) is most effective when taken before or after meals

2026-02-01 22:25:32

Check Details
Dosage adjustment recommendations for patients with hepatic and renal insufficiency when using apremilast (Otelac)

2026-02-01 22:25:32

Check Details
Category
相关知识